Search - tctmd.com

Displaying 1 - 20 of 32

Sort: Relevancy | Date

News Conference News ESC 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Caitlin E. Cox

September 01, 2025

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Conference News ESC 2023

ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients

L.A. McKeown

August 30, 2023

News Daily News

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

L.A. McKeown

December 16, 2022

News Daily News

Initiative Lowers Unnecessary Aspirin Use in Warfarin Users

Todd Neale

September 26, 2022

News Conference News TCT 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

L.A. McKeown

September 17, 2022

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Daily News

Enoxaparin Tops Aspirin for Preventing VTE After Hip or Knee Arthroplasty

Todd Neale

August 25, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Daily News

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

L.A. McKeown

January 20, 2022

News Daily News

FDA Approves Two Additional Indications for Rivaroxaban in Children

L.A. McKeown

December 21, 2021

News Conference News

AXIOMATIC-TKR: Milvexian Promising for VTE Prevention

L.A. McKeown

November 15, 2021

News Daily News

SUNSET sPE: Ultrasound Doesn’t Boost Catheter-Directed Thrombolysis for PE

Todd Neale

June 23, 2021

News Daily News

Papers Confirm Rare Thrombocytopenia Link to AstraZeneca Vaccine

Shelley Wood

April 09, 2021

News Daily News

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Michael O'Riordan

October 27, 2020

News Conference News TCT 2020

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

Michael O'Riordan

October 14, 2020

News Daily News

COVID-19 Clots Spur Both Arterial, Venous Events in Hospitalized Patients

Caitlin E. Cox

July 24, 2020

News Daily News

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

Yael L. Maxwell

July 21, 2020

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Caitlin E. Cox

June 25, 2020

Advertisement

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

November 2024 Dispatch for the CV Team

October 2023 News Roundup

ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

Initiative Lowers Unnecessary Aspirin Use in Warfarin Users

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

Enoxaparin Tops Aspirin for Preventing VTE After Hip or Knee Arthroplasty

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

FDA Approves Two Additional Indications for Rivaroxaban in Children

AXIOMATIC-TKR: Milvexian Promising for VTE Prevention

SUNSET sPE: Ultrasound Doesn’t Boost Catheter-Directed Thrombolysis for PE

Papers Confirm Rare Thrombocytopenia Link to AstraZeneca Vaccine

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

COVID-19 Clots Spur Both Arterial, Venous Events in Hospitalized Patients

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content